Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Moshe Talpaz
Clinical Characteristics and Whole Exome/Transcriptome Sequencing of Coexisting Chronic Myeloid Leukemia and Myelofibrosis
American Journal of Hematology
Hematology
The Clinical Benefit of Ruxolitinib Across Patient Subgroups: Analysis of a Placebo-Controlled, Phase III Study in Patients With Myelofibrosis
British Journal of Haematology
Hematology
Usp5 Links Suppression of P53 and FAS Levels in Melanoma to the BRAF Pathway
Oncotarget
Oncology
Effects of Bosutinib Treatment on Renal Function in Patients With Philadelphia Chromosome-Positive Leukemias
Clinical Lymphoma, Myeloma and Leukemia
Cancer Research
Oncology
Hematology
Down-Regulation of Interleukin-3/Granulocyte-Macrophage Colony-Stimulating Factor Receptor Beta-Chain in BCR-ABL+ Human Leukemic Cells: Association With Loss of Cytokine-Mediated Stat-5 Activation and Protection From Apoptosis After BCR-ABL Inhibition
Blood
Biochemistry
Immunology
Cell Biology
Hematology
Resveratrol Blocks Interleukin-1 -Induced Activation of the Nuclear Transcription Factor NF- B, Inhibits Proliferation, Causes S-Phase Arrest, and Induces Apoptosis of Acute Myeloid Leukemia Cells
Blood
Biochemistry
Immunology
Cell Biology
Hematology
Result of High-Dose Imatinib Mesylate in Patients With Philadelphia Chromosome--Positive Chronic Myeloid Leukemia After Failure of Interferon-
Blood
Biochemistry
Immunology
Cell Biology
Hematology
Imatinib Mesylate Therapy May Overcome the Poor Prognostic Significance of Deletions of Derivative Chromosome 9 in Patients With Chronic Myelogenous Leukemia
Blood
Biochemistry
Immunology
Cell Biology
Hematology
Imatinib Mesylate Resistance Through BCR-ABL Independence in Chronic Myelogenous Leukemia
Cancer Research
Cancer Research
Oncology
